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Left ventricular perforation1. Case report
A 70-year-old woman was hospitalized for shortness of breath on
exertion. She had a history of diabetes and cirrhosis due to hepatitis C.
Cirrhosiswas decompensated andChild–Pugh scorewas B. Transthoracic
echocardiography (TTE) revealed severe AS. She felt that her symptoms
were worsening, but surgical AVR was a high-risk procedure because of
Child–PughClass B cirrhosis and pancytopenia. As TAVIwas not available
in Japan at that time, we decided to perform PTAV in order to improve
the symptoms in heart team conference. PTAV was performed via the
retrograde femoral artery approach under local anesthesia and TTE guid-
ance. Coronary angiography showed that the coronary artery was intact.
Furthermore, the left ventricle-aortic gradientwas 99.9mmHg, andAVA
was 0.72 cm2 as measured by the Gorlin formula. We deployed a pacing
catheter in the right ventricle and conﬁrmed 1:1 capture and a systolic
pressure of b50mmHg at 160 ppm (pace perminute). Next, we crossed
the native aortic valve with a 5-Fr Judkins right diagnostic catheter and
Radifocus® half-stiff straight wire (Terumo, Tokyo, JAPAN) and then ex-
changed the wire for a 0.035-inch Amplatz super-stiff™ guidewire
Straight 3.5 cm Tip (Boston Scientiﬁc, Natick, MA, USA). Aortic annulus
diameter was measured as 18 mm by TTE, and therefore, we chose an
18-mm balloon (Z-MEDII; NuMED, Hopkinton, NY, USA). The balloon
was inﬂated under rapid pacing at 160 ppm; however, the balloon
slipped into the LV, and we immediately pulled the balloon out of the
LV (Fig. 1). Next, we inﬂated the balloon under rapid pacing at
170 ppm, and as a result, the balloon did not slip, and effective
valvuloplasty was provided. However 50 s later, TTE revealed pericardial
effusion, and the patient's blood pressure suddenly dropped. Therefore,
pericardiocentesis was immediately performed, and arterial blood was
aspirated. Moreover, 5000 units of heparin injected at the start of the
procedure was counteracted with 50 mg of protamine sulfate. We
stabilized the patient's hemodynamics by managing the respirator,
intra-aortic balloon pumping, and percutaneous cardiopulmonary
support. However, arterial blood was continuously aspirated through
the pericardial drainage, therefore emergency surgical repair was
performed. Intraoperativeﬁndings included a hematoma and a rip defect
of 3 mm in the lateral LV wall suggesting that the balloon slipping intohttp://dx.doi.org/10.1016/j.ijchv.2014.08.005
2214-7632/© 2014 The Authors. Published by Elsevier B.V. This is an open access article underthe LV at the second balloon inﬂationwas causal. The defectwas repaired
with a bovine pericardial patch. However, the patient died due to
disseminated intravascular coagulation 2 days postoperatively.2. Discussion
Transcatheter aortic valve implantation (TAVI) is recommended in
patients having a high risk for complications related to surgical AVR
[1–3]. Percutaneous aortic valvuloplasty (PTAV) has been considered
to be only temporarily effective, but it is still an important initial
treatment as a bridge to surgical AVR or TAVI in patients who are
hemodynamically unstable or have symptomatic severe AS and require
urgent major non-cardiac surgery [1]. PTAV has the advantage of being
less invasive, but balloon slip is fatal. When the balloon slips, apart from
the loss of curative effect, fatal complications such as LVperforationmay
also occur. Rapid pacing has been reported as a safe and effectivemethod
to provide the transient reduction of cardiac output during balloon inﬂa-
tion, and the balloonmust be inﬂated onlywhen there is 1:1 capture; sys-
tolic pressure is b50 mm Hg, and pulse pressure is b10 mm Hg [4].
In addition, we want to recommend that the stiff wire should be
delivered onto the cardiac apex. The stiff wire is easy to be delivered
on the lateral wall because the stiff wire goes down retrogradely
from left to right through the aortic arch, and tends to go directly
toward the LV lateral wall through the aortic valve. In addition, it is
difﬁcult to deliver the wire onto the apex in small LV cavity due to
concentric hypertrophy in severe AS and the stiff wire is difﬁcult to
maneuver. When the wire is located in the lateral wall, there is a
risk that the balloon sticks into the LV wall if the balloon slips,
because the distance between the aortic valve and the LV lateral
wall is short. To deliver the stiffwire onto the apex,we use the following
technique: we cross the aortic valve with a 5-Fr Judkins right diagnostic
catheter and turn the catheter clockwise in the left anterior oblique
(LAO) and cranial projection after crossing the valve with a 0.035-inch
guidewire. The Judkins right diagnostic catheter is easy to turn toward
the apex, and the stiff wire can be delivered onto the apex. The correct
positioning of the stiff wire onto the apex should be conﬁrmed by sev-
eral methods. Not only frontal view but also RAO projection and LAO
and cranial projection are useful to conﬁrm the position of the stiff
wire (Fig. 2A, B). The correct position of the stiff wire on the LV is critical,
and maximum efforts should be put forth in its placement onto the
apex. And also, TTE is very useful in assessing the position of the wire
(Fig. 2C). Moreover, TTE has the advantage of immediately detecting
complications such as cardiac tamponade, aortic regurgitation, and
mitral regurgitation.
In conclusion, PTAV is one of the therapeutic methods for patients
with severe AS having high risk for surgical AVR and also the
technical basics of TAVI. One of the most critical complications of
PTAV is balloon slip because it is often fatal. Therefore, the placement
of the stiff wire onto the apex is very important to avoid the LV injury
due to balloon slip.the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
Fig. 1. Fluoroscopy at frontal view (A, B) and transthoracic echocardiography (TTE) (C) of the second valvuloplasty, respectively. The stiff wire was located on the lateral wall (A), and the
balloon slipped into the left ventricular (B). TTE showed that the stiff wire was located on the lateral wall (C) (white arrow).
Fig. 2. Fluoroscopy (A, B) and transthoracic echocardiography (TTE) (C) of the case which the stiff wire was located on the apex. A is RAO and B is LAO and cranial projection. TEE is also
useful to conﬁrm the position of the stiff wire. We should deliver the stiff wire to the round apex (white arrow).
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